Biopharma firm Corxel secures $287m to advance lead product pipeline

Biopharma firm Corxel secures $287m to advance lead product pipeline

Photo by Hal Gatewood on Unsplash

26 January, 2026

Edited by: Padma Priya

biopharmaceutical clinical trials Corxel Pharmaceuticals CX11 RTW Investments

Printed by Unregistered user on Wed, 11 Feb 2026 10:17:44 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

KKR leads additional investment in Chinese fungal biotech firm Sylvan

Qiming-backed biotech Oricell raises $70m Series C1 round

Read more from Greater China

US men’s lifestyle brand Playboy to sell 50% of its China business to UTG

ByteDance developing AI chip, in talks with Samsung for manufacturing